- \n
- \nAdvancing strategic priorities in digital health, customer experience and technology modernization\n<\/li>\n
- \nCompleting transition to cloud technology is enabling the company to accelerate its impact in digital health and supply chain efficiency\n<\/li>\n
- \nDigital learning programs underway to upskill workforce\n<\/li>\n<\/ul>\n
DEERFIELD, Ill.–(BUSINESS WIRE<\/a>)–
\nBaxter International Inc. (NYSE:BAX), a global medical products company, is accelerating its companywide digital transformation across three strategic areas \u2013 developing new digital health solutions to personalize and improve patient care; creating seamless experiences for healthcare customers and patients; and modernizing technology capabilities and business processes to deliver data and insights to employees and customers. The company is working with Amazon Web Services, Inc. (AWS) to enable cloud technology solutions to drive its digital transformation forward.\n<\/p>\n\n\u201cOur digital transformation will help us advance our mission to save and sustain lives while delivering value to our patients, clinicians, customers and employees,\u201d said Andy Frye, Baxter\u2019s senior vice president, Asia Pacific, and executive sponsor of the company\u2019s digital transformation. \u201cOur goals are ambitious, and we are collaborating with digital leaders like AWS to reach our goals at speed and scale that will transform Baxter into a company driven by data and insights.\u201d\n<\/p>\n
\nAs part of the companywide effort, Baxter extended its multi-year strategic agreement with AWS to further drive the company\u2019s use of the cloud as a foundational element of its technology infrastructure. For the past several years, the companies have been working together to move Baxter\u2019s physical data centers to the cloud, work which is now nearly complete. Enabling a secure cloud-based foundation has helped modernize many of the company\u2019s platforms and applications, which serve patients, clinicians, customers and employees. When compared to operating physical data centers, the transition to the cloud has delivered several benefits to Baxter, including increased speed to market for new tools and solutions; the ability to quickly expand technology solutions to new geographies; and significant cost savings.\n<\/p>\n
\n\u201cBaxter is using AWS\u2019s broad and deep portfolio of cloud services to deliver new insights and digital health solutions for the millions of patients and caregivers that use their leading portfolio of medical products,\u201d said Greg Pearson, vice president, Worldwide Commercial Sales at AWS. \u201cBaxter\u2019s digital transformation is helping the company unlock the potential of healthcare data and develop a more personalized approach to care, using the unmatched reliability and proven security of one of the world\u2019s leading cloud providers. We look forward to continuing our work with Baxter as the company transforms itself in the cloud, helping drive improved outcomes for patients and new tools for caregivers that improve the quality of care.\u201d\n<\/p>\n
Digital Health Solutions<\/b><\/p>\n
\nBaxter\u2019s cloud infrastructure is foundational to expanding the company\u2019s portfolio of digital health solutions, which span high and low acuity care settings, including home dialysis. The company\u2019s leading Sharesource<\/b> remote patient management platform<\/a> allows healthcare professionals to securely and compliantly monitor their patients\u2019 home dialysis treatments, and then remotely adjust therapy without the need for patients to make unplanned visits to the clinic. Sharesource<\/b> is powered by AWS, which enables Baxter to support daily treatments at scale while also expanding the platform to include new analytics capabilities<\/a>, among other enhancements. Sharesource<\/b> is the most widely adopted home dialysis digital health solution, supporting nearly 46% of home dialysis patients in more than 70 countries. Sharesource<\/b> has been used to manage more than 28 million treatments to date.\n<\/p>\n
\nThe cloud transformation is also supporting Baxter\u2019s DoseEdge<\/b> Pharmacy Workflow Manager<\/a>, an innovative software solution that reduces preventable medication errors from dose preparation in the pharmacy to delivery at the patient\u2019s bedside. DoseEdge<\/b> seamlessly integrates with a hospital\u2019s pharmacy information system to automate the process of routing, preparing, inspecting, tracking, and reporting on IV and oral liquid doses. While the technology is already used in more than 500 hospitals across the U.S., Baxter\u2019s cloud transformation creates an opportunity for accelerated expansion into new markets, while meeting local data security and privacy requirements.\n<\/p>\n
\n“Baxter\u2019s focus on becoming a cloud-driven company is a powerful example of the value of our transformation, from accelerating therapies for patients and enabling safe, quality hospital care to empowering employees with data and insights to drive our business forward. We are proud of our progress with AWS to make this vision a reality,” said Talvis Love, chief information officer, Baxter.\n<\/p>\n
Supply Chain Resilience <\/b><\/p>\n
\nThe pandemic created new challenges for healthcare facilities and global supply chains, from unexpected demand for certain medical products to disruption of raw materials and component availability. Baxter\u2019s cloud infrastructure has enabled the company to proactively, securely and efficiently manage its global supply chain amidst significant uncertainty. Early in the pandemic, rates of acute kidney injury (AKI) among critically-ill COVID-19 patients increased dramatically, leading to higher demand for Baxter\u2019s continuous renal replacement therapy (CRRT) products<\/a> used to treat the condition. AKI is when the kidneys suddenly stop working and\/or cytokine storms develop, which occur when high levels of the inflammatory mediators circulate in the blood as an intense immune reaction to the virus.\n<\/p>\n
\nBaxter\u2019s supply chain team used a suite of cloud-based data and analytics tools in daily simulations and scenario planning to proactively manage and adapt to each new development. This allowed Baxter to activate every possible solution, from maximizing manufacturing capacity in multiple locations to accelerating shipping times. The company also built a complex data model to help validate which hospitals were caring for the highest volumes of critically-ill patients. This model helped the company allocate product based on patient need. Ultimately, Baxter\u2019s digital infrastructure helped its teams deliver more life-sustaining products to customers when they needed them most.\n<\/p>\n
Employee Digital Training<\/b><\/p>\n
\nLooking ahead, the company continues investing in upskilling its global workforce through robust digital learning programs focused on helping employees build digital skills and knowledge that can be harnessed to scale up digital transformation projects across the company\u2019s operations. Beyond this, more than 200 Baxter employees have at least one AWS certification, enabling the company to accelerate innovation and efficiently align to ever changing healthcare and patient needs.\n<\/p>\n
About Baxter<\/b><\/p>\n
\nEvery day, millions of patients and caregivers rely on Baxter\u2019s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For 90 years, we\u2019ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter\u2019s employees worldwide are now building upon the company\u2019s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com<\/a> and follow us on Twitter<\/a>, LinkedIn<\/a> and Facebook<\/a>.\n<\/p>\n
This release includes forward-looking statements based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance for new and existing products; product development risks;<\/i>inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of natural disasters, public health crises and epidemics\/pandemics, regulatory actions or otherwise); satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter’s most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter’s website. Baxter does not undertake to update its forward-looking statements.<\/i><\/p>\n
\nBaxter, Sharesource and DoseEdge are registered trademarks of Baxter International Inc.\n<\/p>\n
<\/p>\n
View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210802005596\/en\/<\/a><\/span><\/p>\n
\nMedia Contact
\n
Lauren Russ, (224) 948-5353
\n
media@baxter.com<\/a><\/p>\n\nInvestor Contact
\n
Clare Trachtman, (224) 948-3020\n<\/p>\nKEYWORDS:<\/b> United States North America Illinois<\/p>\n
INDUSTRY KEYWORDS:<\/b> Software Supply Chain Management Pharmaceutical Data Management Technology Hospitals Security Retail Surgery Medical Supplies Practice Management Health<\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20210802005596\/en\/460336\/3\/Bxtlogo_300dpi.jpg\")
<\/td>\n<\/tr>\n